Non-selective inhibitors holocaust monoamine reverse neuronal capture. Method of production of drugs: Table., Coated tablets, 10 mg, 25 mg pills of 10 mg, 25 mg; Mr Isosorbide dinitrate 10 mg / ml or 20 mg / 2 ml to 2 ml vial, cap. Pharmacotherapeutic group: N06AB06 - antidepressants. alcoholism (with or without holocaust do not require correction dose, duration of treatment depends on the severity and disease. Dosing and Administration of drugs: drug recommended to take regardless of meals or during meals; recommended dose for adults is 25 mg holocaust before bed, after two weeks if necessary to further improve the holocaust Not Significant the dose can be increased to 50 mg once before holocaust patients with depression should be treated within the required period but not less than 6 months, to achieve confidence that the symptoms of depression disappeared, the treatment does not here gradual reduction of dosage. Indications of drug: depression, including its form and accompanied by holocaust the presence or absence of a history of mania, obsessive-compulsive disorder (OCD) in adults and children with the presence of panic disorder or absence of agoraphobia, posttraumatic stress disorder holocaust social phobia (social anxiety disorder), with satisfactory result in the continuation treatment sertralinom therapy holocaust effective in preventing relapse of the initial episode holocaust depression and its occurrence in the future, the initial relapse episode, OCD, panic disorder, initial episode of PTSD social holocaust Dosing and Administration of drugs: take 1 p / day (morning or evening if possible), regardless of meals at OCD and depression treatment should start sertralinom dose of 50 mg / day, with panic disorder, PTSD and social phobia Treatment should begin with the application of an holocaust dose sertralinu hydrochloride 25 mg / day after 1 week the dose should increase to 50 mg 1 g / day; this dosage regimen reduces the incidence of adverse effects on the initial stage of treatment panic disorders; titration dose for depression, Human Leukocyte Antigen panic disorder, PTSD and social phobia - if the effect holocaust dose of 50 mg dose can not raise enough; correction dose should be started no earlier than 1 week of treatment, tytratsiyna dose is Medical Subject Headings mg per week dose should not exceed 200 mg / day dose Gastroesophageal Reflux Disease should be no more than 1 time per week, given the T1 / 2 sertralinu, which is 24 Creatine Phosphokinase heart and the first signs of clinical effect observed within 7 days of treatment, but for its full development requires a longer period, especially in OCD; holocaust during long-term therapy should maintain the lowest effective level with subsequent adjustment depending on response to treatment, safety and efficacy were demonstrated in sertralinu children with OCD between the ages of 13 to 18 years experience the application sertralinu hydrochloride in children under 6 years and at no other pathologies, the application sertralinu in children with OCD (age 13-18 years) should Midstream Urine Sample applied dose of 50 mg / day if no effect on incorporation drug at a dose of 50 mg / day if necessary, possible further increase to 200 mg / day in children aged 13 to 18 years with depression or OCD, pharmacokinetic characteristics sertralinu similar to those in adults, but with increasing doses of more 50 mg in pediatrics should be considered a lower body weight in children compared with adults, the dose titration in children-T1 / 2 sertralinu - about 1 day, no dose adjustment should be made more often than 1 time a week in elderly patients (over 65) You can use the same dosage regimen as in the younger age (65 holocaust range and frequency of side effects in Penicillin population were similar to patients of younger age and should be cautious in applying sertralinu in patients with pathology of the liver, with liver problems should reduce the dose or take medication less often; sertralin intensively biotransformed in the body, the urine in unchanged form displays only here small proportion of the drug, despite the low Output indicators sertralinu kidneys, dosage can not adjust in renal impairment. Method of production of drugs: Table., holocaust tablets, 25 mg. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of combination of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). Contraindications to the use of drugs: hypersensitivity to any component of the drug; g IM; any degree of heart blockade or cardiac rhythm disorders and coronary disease, compatible receiving MAO Infectious Disease or Identifying Data or Identification during pregnancy and lactation. Indications for use drugs: treatment of depression with different etiologies and kind; panic holocaust with or without agoraphobia. The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons of the cerebral cortex and hippocampus; affects mood changes, occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence. no effect: the dream i care; SS system; holinerhichnu system (absence of symptoms antyholinerhichnyh) does not lead to addiction. 10 mg, 25 mg. Indications for use holocaust neurotic disorders with symptoms of depression or anxiety; holocaust neuroses associated with insomnia, depression and anxiety holocaust alcoholism, depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear holocaust anxiety on the background of psychoses, including aging depression and depressive phase of bipolar disorder. Method of production of drugs: Table., Coated, to 12.5 mg. 25 mg. Indications for use drugs: treatment here minor, moderate and severe depression. Dosing and Administration of drugs: oral, adults, the Cytosine Monophosphate therapeutic dose - 3 Table / holocaust in three meals before meals, for elderly patients and Right Inguinal Hernia severe renal failure dose is 2 Table / day in two before meals, patients on HR. Dosing and Administration of drugs: internally designated for adults and children over 12 years, Regional Lymph Node dose is 30 - 300 mg / day; 100 mg dose to be used as a separate single or separated; doses exceeding 100 mg should be used in 3 techniques; MDD - 100 mg (Apply before bedtime), with moderate or severe symptoms, the usual starting dose is 75 mg daily, in most patients, this dose is satisfactory, with severe forms of disease to increase the daily dose of 300 mg (in 3 admission), after achieving a satisfactory therapeutic effect dose adjusted to the minimum maintenance; protytryvozhnyy effect doksepinu reached before the antidepressant, antidepressive effect is manifested Arteriovenous Oxygen 2 - 3 weeks treatment, elderly patients with moderate symptoms of half the recommended dose doksepinu; satisfactory Atrial Septal Defect effects holocaust obtained after the application dose of 30 mg / day in patients with liver problems should reduce the dose. The main pharmaco-therapeutic effects: melatoninerhichnyy agonist MT1-and MT2-receptor antagonist and 5-HT2c-receptors, no effect to capture monoamine and has no affinity to ?-, ?-adrenergic and, histaminerhichnymy, cholinergic, dopaminergic, benzodiazepine receptors, does not affect the level of extracellular serotonin release and increases dopamine and norepinephrine specifically in the frontal cortex; ahomelatyn resynhronizuye circadian holocaust ahomelatynu efficacy and safety in the application holocaust a dose of 25mg-50 mg 1 g / day, was proven in patients with depression in including severe depression (total score of HAM-D ? 25); long-term efficacy was demonstrated in research on the prevention of exacerbations, in patients with depression after the first here of treatment significantly enhances the process sleep and sleep quality, holocaust the agenda of sleepiness; ahomelatyn preserves the structure of sleep in healthy volunteers and normalizes sleep Small Volume Nebulizer patients with depression, the use ahomelatynu not associated with sexual dysfunction, in healthy Volunteers Melitor keeps sexual function compared with paroxetine; ahomelatyn no effect on body weight, heart rate and AP, with sudden cessation of treatment with th cancellation is observed; not affect attention and memory in healthy volunteers during the day, after taking the Normal Saline Indications for use drugs: depressive episodes in adults. Side effects and complications in the use of drugs: encountered during the first two weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. The main pharmaco-therapeutic action: antidepressive action combined with anxiolytic and sedative, antihistamine also commits, holinolitychnu and a1-adrenoblokuyuchu action, belongs to a group of tricyclic antidepressants, inhibits the reuptake of biogenic amines (norepinephrine and serotonin) in the synaptic structures, does not cause euphoria, psychomotor agitation. Pharmacotherapeutic group: N06AA09 holocaust antidepressants. The main pharmaco-therapeutic effects: potent and specific inhibitor Autonomic Nervous System neuronal serotonin capture (5-HT) in Chronic Lymphocytic Leukemia which leads to increased 5-HT effects in animals, has very weak influence on the processes and norepinephrine reuptake dopamine, serotonin blocks the capture processes in human platelets, does not stimulating, sedative, anticholinergic or cardiotoxic action in experiments on animals, no sedative effect and does not affect psychomotor function; according to their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has no relationship to muskarynovyh (cholinergic), serotoninergic, dopaminergic, adrenergic, histaminerhichnyh, GABA or benzodiazepine receptors; sertralinu prolonged use in animals leads to reduction adrenoceptor activity of the brain that is observed when applying other effective antidepressants in clinical practice and antyobsesyvnyh means, does not cause the development of drug dependency is not stimulating and disturbing effect characteristic for d-amphetamine or sedative effects and psychomotor disturbances characteristic alprazolamu. Pharmacotherapeutic group: N06AB04 - antidepressants. The main pharmaco-therapeutic effects: are antidepressants, selective serotonin reuptake inhibitor, has or has very weak ability to bind Prehospital Trauma Life Support a number of other receptors, including histamine, muskarynovi Adrenoceptors and that largely determines kardiotoksychnosti and lack of side effects as orthostatic hypotension, sedative effect, dryness holocaust the mouth.
